MiyauchiA, ItoY, FujishimaM, et al.Long-Term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-Year experience. Thyroid, 2023; 33(7):817–825; doi: 10.1089/thy.2023.0076
2.
HamidiS, IyerPC, DaduR, et al.Checkpoint inhibition in addition to Dabrafenib/Trametinib for BRAFV600E-Mutated anaplastic thyroid carcinoma. Thyroid, 2024; 34(3):336–346; doi: 10.1089/thy.2023.0573
3.
HuwilerVV, Maissen-AbgottsponS, StangaZ, et al.Selenium supplementation in patients with hashimoto thyroiditis: A systematic review and meta-analysis of randomized clinical trials. Thyroid, 2024; 34(3):295–313; doi: 10.1089/thy.2023.0556
4.
SentisSC, DoreR, OelkrugR, et al.Hypothalamic thyroid hormone receptor α1 signaling controls body temperature. Thyroid, 2024; 34(2):243–251; doi: 10.1089/thy.2023.0513
